All Access Articles |
- Alnylam Pharmaceuticals Promotes Pushkal Garg to Chief R&D Officer | 2025-06-20 |
- Alnylam Pharmaceuticals Promotes Pushkal Garg to Executive VP & Chief R&D Officer | 2025-06-19 | PHARMACEUTICAL
- Alnylam Pharmaceuticals' $7.35 Billion Accumulated Deficit | 2025-05-01 | PHARMACEUTICAL
- FDA Approves Alnylam's Amvuttra® for Rare Disease | 2025-03-21 | PHARMACEUTICAL